TOP NEWS
Home >> Marketplace Directory >> FDA expands pembrolizumab indication for NSCLC

FDA expands pembrolizumab indication for NSCLC

in Marketplace Directory

image_pdfCreate PDF

Merck, 908-740-4000
Agilent Technologies, 408-345-8886

Pages: 1 2

Tagged with:

CAP TODAY
X